FacultyFaculty/Author Profile

Charlene Keller Fullmer

US Attorney's Office, Eastern District of Pennsylvania

Philadelphia, PA, USA


Assistant United States Attorney Charlene Keller Fullmer is the Deputy Chief for Affirmative Litigation in the Civil Division of the United States Attorney’s Office in the Eastern District of Pennsylvania, where she supervises and prosecutes health care and affirmative fraud matters. She led the Philadelphia civil prosecution team that investigated and resolved allegations of off-label promotion of the atypical antipsychotic drug Risperdal by Johnson and Johnson and its subsidiary Janssen Pharmaceuticals, which resulted in a $2.2 billion global settlement with the Department of Justice, the largest paid for a single drug. In 2009, she served on the team that investigated and resolved allegations of off-label promotion and kickbacks by Pfizer, Inc. The $2.3 billion civil and criminal resolution was at the time the largest health care fraud settlement in the history of the Department of Justice. For her efforts in these matters, she was the recipient of the 2014 Attorney General’s Award for Fraud Prevention, an Award of Commendation from the Assistant Attorney General for the Civil Division, Tony West, and the 2014 National Health Care Anti-Fraud Association’s Investigation of the Year. In October 2010, Attorney General Eric Holder presented her with the Attorney General Award for Exceptional Service, the Department of Justice’s highest commendation.

Ms. Fullmer returned to the Justice Department in 2007 after six years in private practice at Duane Morris LLP in Philadelphia, where she litigated defensive matters, including False Claims Act, health care, white collar, antitrust, and insurance coverage litigation. Prior to that time, she served as an Attorney Advisor in Washington, DC and Quantico, VA with the Federal Bureau of Investigation, Office of Professional Responsibility, the Bureau’s Internal Affairs.

She is a 1993 graduate of Lehigh University, cum laude, and a 1996 graduate of Temple University School of Law, cum laude, where she served on the Law Review.

Charlene Keller Fullmer is associated with the following items:
Web Segment  Web Segment Enforcement Trends Impacting the Drug and Device Industries - Life Sciences 2017: Navigating Legal Challenges in the Drug and Device Industries, Thursday, October 12, 2017
MP3 Audio  MP3 Audio Enforcement Trends Impacting the Drug and Device Industries - Enforcement Trends Impacting the Drug and Device Industries, Thursday, October 12, 2017
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Enforcement Trends Impacting the Drug and Device Industries - Enforcement Trends Impacting the Drug and Device Industries, Thursday, October 12, 2017
On-Demand Web Programs  On-Demand Web Programs Life Sciences 2017: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, October 18, 2017, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.